Heron Therapeutics
HRTX
HRTX
92 hedge funds and large institutions have $848M invested in Heron Therapeutics in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 46 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 99 → 92 (-7)
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
Holders
92
Holding in Top 10
5
Calls
$13.6M
Puts
$6.25M
Top Buyers
| 1 | +$18.2M | |
| 2 | +$9.32M | |
| 3 | +$8.63M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$5.01M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$4.93M |
Top Sellers
| 1 | -$4.65M | |
| 2 | -$4.27M | |
| 3 | -$3.89M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.87M |
| 5 |
Goldman Sachs
New York
|
-$2.64M |